1 Min Read
March 29 (Reuters) - Sanofi India Ltd:
* Clarifies on news item “FDA approves Regeneron, Sanofi $37,000 per year eczema drug”
* News is not relating to ops of Sanofi India Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.